Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04193293
Title A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

Therapies

Duvelisib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.